IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
92 hedge funds and large institutions have $1.13B invested in IVERIC bio, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 25 reducing their positions, and 20 closing their positions.
32% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 25
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
4% less capital invested
Capital invested by funds: $1.18B → $1.13B (-$51.1M)
6% less funds holding
Funds holding: 98 → 92 (-6)
10% less call options, than puts
Call options by funds: $6M | Put options by funds: $6.67M
30% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 20
Top Buyers
| 1 |
JCG
JHL Capital Group
Chicago,
Illinois
|
+$13.3M |
| 2 |
O
OrbiMed
New York
|
+$13.3M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$6.9M |
| 4 |
PA
Perceptive Advisors
New York
|
+$5.84M |
| 5 |
State Street
Boston,
Massachusetts
|
+$3.3M |
Top Sellers
ISEE Hedge Fund Activity: Q3 2014 in Review
92 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q3 2014, worth a combined $1.13B — down 4.3% from $1.18B a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of ISEE and 14 opened new positions — a net loss of 6 holders — while 25 trimmed existing stakes and 33 added.
The largest buyer was JHL Capital Group, adding an estimated $13.3M. The largest seller was Fort Washington Investment Advisors, cutting an estimated $5.01M.
- 92 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q3 2014, down from 98 in Q2 2014.
- Funds reported $1.13B of IVERIC bio, Inc. Common Stock stock for Q3 2014, down 4.3% quarter-over-quarter.
- 14 funds opened new IVERIC bio, Inc. Common Stock positions in Q3 2014 and 20 closed out, a net change of -6 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q3 2014 was JHL Capital Group, an estimated $13.3M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q3 2014 was Fort Washington Investment Advisors, an estimated $5.01M sold.
Based on aggregated 13F filings for Q3 2014.